Calculating the risk of glaucoma
More than 1000 people have completed an online assessment in Australian pharmacies to determine their potential risk of developing glaucoma, and there's a call...
The new normal
A new PSA report describes the digital future of Australian health care, a ‘new normal’ with pharmacists front and centre, equipped with more information...
Reducing stroke risk in dementia patients
A commonly-used treatment for Alzheimer's disease could reduce the risk of stroke among people with dementia.
The Australian-Swedish study, co-authored by Monash University researchers, focussed...
Indirect impacts of COVID-19
Australia has had relative success in suppressing the COVID-19 virus, but there continues to be myriad ongoing and wide ranging indirect impacts.
Antioxidants and mineral supplements for slowing age-related macular degeneration
Age-related macular degeneration (AMD) is the most common cause of blindness in developed countries. The prevalence of AMD is 1.4% at 70 years of...
PSA’s critical role in 7CPA in spotlight
Federal Health Minister Greg Hunt has asserted the critical role that PSA will play in drafting the 7th Community Pharmacy Agreement (CPA), shaping the...
